Genpharmasec Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 ,inter alia, to consider and approve 1. To consider and approve Un-audited ....

GENPHARMASEC LIMITED Date: 03.08.2026 BSE Limited The Compliance Department of Corporate Services, Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai - 400 001. Scrip Code: 531592 Subject: Intimation of Board Meeting to be held on Tuesday, 11th August, 2026. Dear Sir/Madam, With reference to the above captioned subject and in accordance with Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Meeting of Board of Directors of our Company will be held on Tuesday, 11% August, 2026 at the Registered Office of the Company, to consider and approve, inter alia other matters, the following: 1. To consider and approve Un-audited Standalone and Consolidated Financial Results of the Company along with the Limited Review Report for the quarter ended 30% June, 2026. 2. To consider any other business with the permission of a Chairman. Further, Pursuant to the provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015 and Company’s Code of Conduct for Prevention of Insider Trading, the trading window for all Directors, Designated Persons, their immediate relatives and specified Connected Persons has been kept closed for dealing in the securities of the Company from July 01, 2026 till 48 hours after the declaration of Un-Audited Standalone and Consolidated Financial Results of the Company for the quarter ended 30t June 2026. Kindly take the same on records for your perusal. Thanking you, For and behalf of the Board of Director of, Genpharmasec Limited Digtally signed by \ SOHAN SOHAN CHATURVEDI Date: 2026.08.03 CHATURVEDI 2 50 X Mr. Sohan Chaturvedi Whole time director & CFO DIN- 09629728 104 & 105, 1st Floor, Gundecha Industrial Premises Co-Operative Soc @ compliance@genpharmasec.com Ltd., Akurli Road, Kandivali (East), Mumbai 400101. info@genpharmasec.com (©) +91-86555 50242 @ www.genpharmasec.com CIN : L24231MH1992PLC323914